(Q73711918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

J L Swischuk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P F Fox

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

K Young

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Hussain

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

B Smouse

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F Castañeda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T M Brady

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

Journal of Vascular and Interventional Radiology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

423-430

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE Trial

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Plasminogen activators: pharmacology and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Recombinant human tissue-type plasminogen activator for thrombolysis in peripheral arteries and bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Evolving strategies for thrombolytic therapy of peripheral vascular occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Local thrombolytic therapy of acute peripheral arterial ischaemia with tissue plasminogen activator: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Peripheral thrombolysis with tissue plasminogen activator. Results of two treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Recombinant Tissue Plasminogen Activator for the Treatment of Lower Extremity Peripheral Vascular Occlusive Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Intraarterial catheter-directed thrombolysis: urokinase versus tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Thrombolytic therapy with recombinant human tissue-type plasminogen activator: a comparison of two doses

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissue-type plasminogen activator--report of a pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Efficacy and tolerance of recombinant tissue-type plasminogen activator in patients with thrombotic or embolic occlusions of leg-arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Thrombolysis with tissue-plasminogen activator: results with a high-dose transthrombus technique

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Re: "Thrombolysis with tissue-plasminogen activator: results with a high-dose transthrombus technique". Thrombolysis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Accelerated thrombolysis with high dose bolus t-PA extends the role of peripheral thrombolysis but may increase the risks

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Peripheral arterial occlusions: local low-dose thrombolytic therapy with recombinant tissue-type plasminogen activator (rt-PA).

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Comparison of tissue plasminogen activator and urokinase in the local infiltration thrombolysis of peripheral arterial occlusions

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Rationale for bolus t-PA therapy to improve efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

A simplified procedure for intra-arterial thrombolysis with tissue-type plasminogen activator in peripheral arterial occlusive disease: primary and long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Recombinant tissue-type plasminogen activator is superior to streptokinase for local intra-arterial thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Tissue plasminogen activator in peripheral arterial thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

Low doses of recombinant human tissue-type plasminogen activator for local thrombolysis in peripheral arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961879-X

7 January 2021

10.1016/S1051-0443(07)61879-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11287527%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference